{"id":"https://openalex.org/W3008742575","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.731","title":"Longitudinal multiplex cytokine analysis for patients (pts) with metastatic renal cell carcinoma (mRCC) treated with ipilimumab/nivolumab (I+N).","display_name":"Longitudinal multiplex cytokine analysis for patients (pts) with metastatic renal cell carcinoma (mRCC) treated with ipilimumab/nivolumab (I+N).","publication_year":2020,"publication_date":"2020-02-19","ids":{"openalex":"https://openalex.org/W3008742575","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.731","mag":"3008742575"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.6_suppl.731","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.731","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.6_suppl.731","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100371721","display_name":"Tian Zhang","orcid":"https://orcid.org/0000-0001-8914-3531","observed_orcids":["https://orcid.org/0000-0001-8914-3531","https://orcid.org/0000-0001-7959-5569"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tian Zhang","raw_affiliation_strings":["Duke Cancer Institute, Duke University, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute, Duke University, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071026407","display_name":"Yuan Wu","orcid":"https://orcid.org/0000-0003-2663-7766","observed_orcids":["https://orcid.org/0000-0003-2663-7766"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuan Wu","raw_affiliation_strings":["Department of Biostatistics and Bioinformatics, Duke Cancer Institute, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Bioinformatics, Duke Cancer Institute, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103138715","display_name":"Anika Agarwal","orcid":"https://orcid.org/0000-0002-8820-7297","observed_orcids":["https://orcid.org/0000-0002-8820-7297"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anika Agarwal","raw_affiliation_strings":["Duke University, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC;","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062010101","display_name":"Mark D. Starr","orcid":"https://orcid.org/0009-0003-9664-6235","observed_orcids":["https://orcid.org/0009-0003-9664-6235"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark D. Starr","raw_affiliation_strings":["Duke University Medical Center, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC;","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018350039","display_name":"Marco Reyes-Martinez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marco Reyes-Martinez","raw_affiliation_strings":["Duke University, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC;","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033835226","display_name":"Monika Anand","orcid":"https://orcid.org/0000-0001-8634-4952","observed_orcids":["https://orcid.org/0000-0001-8634-4952"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monika Anand","raw_affiliation_strings":["Duke University, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC;","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062117905","display_name":"Daniella Runyambo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniella Runyambo","raw_affiliation_strings":["Duke Cancer Institute, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000997350","display_name":"Michael Roger Harrison","orcid":"https://orcid.org/0000-0003-3776-8892","observed_orcids":["https://orcid.org/0000-0003-3776-8892"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Roger Harrison","raw_affiliation_strings":["Duke Cancer Institute, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038489185","display_name":"Andrew J. Armstrong","orcid":"https://orcid.org/0000-0001-7012-1754","observed_orcids":["https://orcid.org/0000-0001-7012-1754"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J. Armstrong","raw_affiliation_strings":["Duke Cancer Institute, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020223699","display_name":"Daniel J. George","orcid":"https://orcid.org/0000-0003-1499-7203","observed_orcids":["https://orcid.org/0000-0003-1499-7203","https://orcid.org/0000-0002-0836-8542"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. George","raw_affiliation_strings":["Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044586794","display_name":"Andrew B. Nixon","orcid":"https://orcid.org/0000-0003-3971-2964","observed_orcids":["https://orcid.org/0000-0003-3971-2964"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew B. Nixon","raw_affiliation_strings":["Duke University Medical Center, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC;","institution_ids":["https://openalex.org/I4210126298"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"6_suppl","first_page":"731","last_page":"731"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.8823000192642212,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.8823000192642212,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.11180000007152557,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9679999947547913},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8790000081062317},{"id":"https://openalex.org/keywords/serum-cytokines","display_name":"serum cytokines","score":0.8489999771118164},{"id":"https://openalex.org/keywords/plasma-biomarkers","display_name":"plasma biomarkers","score":0.6019999980926514},{"id":"https://openalex.org/keywords/macrophage-inflammatory-protein-1beta","display_name":"macrophage inflammatory protein-1\u03b2","score":0.8080000281333923},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.7160000205039978},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7459999918937683},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.6779999732971191},{"id":"https://openalex.org/keywords/interleukin-7","display_name":"IL-7","score":0.6869999766349792},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.8730000257492065},{"id":"https://openalex.org/keywords/icam-1","display_name":"ICAM-1","score":0.8270000219345093},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8980000019073486},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9860000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9027454853057861},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5812627077102661},{"id":"https://openalex.org/C2777716647","wikidata":"https://www.wikidata.org/wiki/Q5381961","display_name":"Eotaxin","level":4,"score":0.5713174939155579},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.523609459400177},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4950255751609802},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34092649817466736},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32317960262298584},{"id":"https://openalex.org/C2777037409","wikidata":"https://www.wikidata.org/wiki/Q107238","display_name":"Eosinophil","level":3,"score":0.21107423305511475},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.15847325325012207}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.6_suppl.731","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.731","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.6_suppl.731","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389480718","https://openalex.org/W4212997217","https://openalex.org/W3133949022","https://openalex.org/W3134715671","https://openalex.org/W4295837204","https://openalex.org/W4406145094","https://openalex.org/W3007601511","https://openalex.org/W4310753920","https://openalex.org/W4400187115","https://openalex.org/W4400959370"],"abstract_inverted_index":{"731":[0],"Background:":[1],"I+N":[2,38],"is":[3,269],"an":[4],"established":[5],"treatment":[6],"for":[7,192],"mRCC,":[8],"where":[9],"circulating":[10,22,267],"protein":[11],"biomarkers":[12],"are":[13,140,156,254,290],"prognostic.":[14],"In":[15,245],"a":[16,81,144,250],"longitudinal":[17],"correlative":[18],"study,":[19],"we":[20],"characterized":[21,61],"proteins":[23],"in":[24,181,226,230,258,266],"mRCC":[25,34,164],"pts":[26,35,162,183,186,196,232],"treated":[27,36],"with":[28,37,143,163,271],"standard":[29,135],"of":[30,137,252],"care":[31],"I+N.":[32,286],"Methods:":[33],"were":[39,60,179],"prospectively":[40],"enrolled":[41,160],"at":[42,50,197,256],"Duke":[43],"Cancer":[44],"Institute":[45],"(NCT02978118),":[46],"contributing":[47],"EDTA":[48],"plasma":[49],"baseline,":[51],"week(wk)-4,":[52],"wk-12,":[53],"and":[54,131,134,151,167,177,200,228,275,283],"disease":[55,63,74],"progression.":[56],"Best":[57],"overall":[58],"responses":[59],"as":[62],"control":[64],"(DC;":[65],"stable":[66],"disease,":[67],"partial":[68],"&":[69,114,118],"complete":[70],"responses)":[71],"versus":[72],"progressive":[73],"(PD).":[75],"Plasma":[76],"was":[77,189],"batch":[78],"analyzed":[79],"using":[80],"46-plex":[82],"MesoScale":[83],"Discovery":[84],"ELISA":[85],"assay":[86],"(IFN-g,":[87],"interleukins":[88],"[IL]-1b,":[89],"2,":[90],"4,":[91],"5,":[92],"6,":[93],"7,":[94],"8,":[95],"10,":[96],"12,":[97],"IL-12-IL-23p40,":[98,173],"13,":[99],"15,":[100],"16,":[101],"17A,":[102],"21,":[103],"22,":[104],"27,":[105],"31,":[106],"MIP-3a,":[107],"Eotaxin,":[108],"Eotaxin-3,":[109],"IP-10,":[110],"MCP-1&4,":[111],"MDC,":[112],"MIP-1a":[113],"1b,":[115],"TARC,":[116],"TNF-a":[117],"b,":[119],"GM-CSF,":[120],"CRP,":[121],"ICAM-1,":[122,174],"SAA,":[123],"VCAM-1,":[124],"FGFb,":[125],"FLT-1,":[126],"PlGF,":[127],"Tie-2,":[128],"VEGF,":[129],"VEGF-,":[130],"VEGF-D).":[132],"Mean":[133],"deviations":[136],"cytokine":[138],"concentrations":[139],"reported,":[141],"along":[142],"Wilcoxon":[145],"rank":[146],"sum":[147],"test":[148],"between":[149,220],"PD":[150,182,193,231,237,261,274],"DC":[152,166,185,195,207,227,259,272],"groups;":[153],"unadjusted":[154],"p-values":[155],"nominal.":[157],"Results:":[158],"We":[159],"25":[161],"(15":[165],"10":[168],"PD).":[169],"Baseline":[170],"IL-7,":[171],"IL-8,":[172],"TNF-a,":[175],"VEGF-C,":[176],"VEGF-D":[178],"lower":[180,191],"than":[184,194,260],"(Table).":[187],"MIP-1b":[188],"significantly":[190,224],"baseline":[198,215,257],"(Table)":[199],"wk-4":[201,222,264],"change":[202],"(PD":[203],"0.30":[204],"+/-":[205,209,235,239],"1.82,":[206],"0.83":[208],"6.49,":[210],"p":[211,241],"=":[212,242],"0.056).":[213,243],"Although":[214],"IFN-g":[216,223,268],"did":[217],"not":[218],"differ":[219],"groups,":[221],"increased":[225,280],"decreased":[229],"(DC":[233],"3.5":[234],"7.1;":[236],"-1.33":[238],"5.47,":[240],"Conclusions:":[244],"this":[246],"pilot":[247],"exploratory":[248],"analysis,":[249],"subset":[251],"ILs":[253],"higher":[255],"pts.":[262],"A":[263],"increase":[265],"associated":[270],"vs":[273],"could":[276],"be":[277],"linked":[278],"to":[279,285,292],"early":[281],"inflammation":[282],"response":[284],"Larger":[287],"prospective":[288],"studies":[289],"needed":[291],"validate":[293],"these":[294],"findings.[Table:":[295],"see":[296],"text]":[297]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-03-06T00:00:00"}